Fig. 2From: A new age for biomedical applications of Ribosome Inactivating Proteins (RIPs): from bioconjugate to nanoconstructsPutative RIP based conjugates. a ImmunoRIPs obtained fusing RIPs to antibody (left) or minibody, as scFv (right). b Alternative bioconiujates obtained fusing RIPs to receptors (left), cellular ligands (center) and protease inhibitors (right)Back to article page